Exact Mass: 377.1173

Exact Mass Matches: 377.1173

Found 57 metabolites which its exact mass value is equals to given mass value 377.1173, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

6-(2-Hydroxyethyl)-5,6-dihydrosanguinarine

6-(2-Hydroxyethyl)-5,6-dihydrosanguinarine

C22H19NO5 (377.1263)


   

JNJ-38877605

JNJ-38877605

C19H13F2N7 (377.12)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

S-(2-Hydroxy-3-buten-1-yl)glutathione

2-Amino-5-[[1-(carboxymethylamino)-3-(2-hydroxybut-3-enylsulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C14H23N3O7S (377.1257)


   

(2S)-2-(Butanoylamino)-5-[[(1R)-2-(carboxymethylamino)-2-oxo-1-(sulfanylmethyl)ethyl]amino]-5-oxo-pentanoic acid

(2S)-2-(Butanoylamino)-5-[[(1R)-2-(carboxymethylamino)-2-oxo-1-(sulphanylmethyl)ethyl]amino]-5-oxo-pentanoic acid

C14H23N3O7S (377.1257)


   

Ethoxysanguinarine

23-ethoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0^{2,10.0^{4,8.0^{14,22.0^{17,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene

C22H19NO5 (377.1263)


Ethoxysanguinarine is a benzophenanthridine alkaloid natural product that is mainly found in Macleaya cordata. Ethoxysanguinarine is an inhibitor of protein phosphatase 2A (CIP2A). Ethoxysanguinarine induces cell apoptosis and inhibits colorectal cancer cells growth[1]. Ethoxysanguinarine is a benzophenanthridine alkaloid natural product that is mainly found in Macleaya cordata. Ethoxysanguinarine is an inhibitor of protein phosphatase 2A (CIP2A). Ethoxysanguinarine induces cell apoptosis and inhibits colorectal cancer cells growth[1].

   
   

Piscerythoxazole

7-Hydroxy-5-methoxy-2-prenyloxazol[2,3:4,3]isoflavone

C22H19NO5 (377.1263)


   

FMOC-DL-2-furylalanine

FMOC-DL-2-furylalanine

C22H19NO5 (377.1263)


   

S-4-(2-oxo-butyl)glutathione

S-4-(2-oxo-butyl)glutathione

C14H23N3O7S (377.1257)


   

L-gamma-glutamyl-S-3-(1-oxobutyl)-L-cysteinyl-glycine

L-gamma-glutamyl-S-3-(1-oxobutyl)-L-cysteinyl-glycine

C14H23N3O7S (377.1257)


This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.

   

O1-(2-acetylamino-[1]naphthyl)-beta-D-glucopyranuronic acid|O1-(2-Acetylamino-[1]naphthyl)-beta-D-glucopyranuronsaeure

O1-(2-acetylamino-[1]naphthyl)-beta-D-glucopyranuronic acid|O1-(2-Acetylamino-[1]naphthyl)-beta-D-glucopyranuronsaeure

C18H19NO8 (377.1111)


   

4-methoxyfuro[2,3-b]quinolin-7-yl beta-D-mannopyranoside|dictamnine-7-beta-D-mannopyranoside

4-methoxyfuro[2,3-b]quinolin-7-yl beta-D-mannopyranoside|dictamnine-7-beta-D-mannopyranoside

C18H19NO8 (377.1111)


   

(2-hydroxy-1-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-acetaldehyde|11-(Formyl-methylenyl)-O-desmethyl-dihydrochelerythrin

(2-hydroxy-1-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-acetaldehyde|11-(Formyl-methylenyl)-O-desmethyl-dihydrochelerythrin

C22H19NO5 (377.1263)


   
   

O1-(6-acetylamino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Acetylamino-[2]naphthyl)-beta-D-glucopyranuronsaeure

O1-(6-acetylamino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Acetylamino-[2]naphthyl)-beta-D-glucopyranuronsaeure

C18H19NO8 (377.1111)


   

14-Ethoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridine

14-Ethoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridine

C22H19NO5 (377.1263)


   

Polanrazine B_120170

Polanrazine B_120170

C18H23N3O2S2 (377.1232)


   

3-[[2-(4-phenylmethoxyphenoxy)acetyl]amino]benzoic acid

3-[[2-(4-phenylmethoxyphenoxy)acetyl]amino]benzoic acid

C22H19NO5 (377.1263)


   

disperse blue 124

2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethyl acetate

C16H19N5O4S (377.1158)


   

Disperse Orange 29

Disperse Orange 29

C19H15N5O4 (377.1124)


   
   

Fmoc-D-2-Furylalanine

Fmoc-D-2-Furylalanine

C22H19NO5 (377.1263)


   

Fmoc-L-2-Furylalanine

Fmoc-L-2-Furylalanine

C22H19NO5 (377.1263)


   

5-(4-TERT-BUTYLPHENYL)-4-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-TRIAZOLE-3-THIOL

5-(4-TERT-BUTYLPHENYL)-4-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-TRIAZOLE-3-THIOL

C19H18F3N3S (377.1173)


   

CH5132799

5-(7-(methylsulfonyl)-2-morpholino-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine

C15H19N7O3S (377.127)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

1,2-di-o-acetyl-3-azido-3-deoxy-5-o-toluoyl-d-ribofuranose

1,2-di-o-acetyl-3-azido-3-deoxy-5-o-toluoyl-d-ribofuranose

C17H19N3O7 (377.1223)


   

Selurampanel

Selurampanel

C16H19N5O4S (377.1158)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

   

Ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate

Ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate

C18H20FN3O3S (377.1209)


   

4-[[2-methoxy-4-[(4-nitrophenyl)azo]phenyl]azo]phenol

4-[[2-methoxy-4-[(4-nitrophenyl)azo]phenyl]azo]phenol

C19H15N5O4 (377.1124)


   

Dasolampanel

Dasolampanel

C17H20ClN5O3 (377.1255)


C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

N-(2-methoxydibenzofuran-3-yl)-2-(4-methoxyphenoxy)acetamide

N-(2-methoxydibenzofuran-3-yl)-2-(4-methoxyphenoxy)acetamide

C22H19NO5 (377.1263)


   

S-(4-oxobutan-2-yl)glutathione

S-(4-oxobutan-2-yl)glutathione

C14H23N3O7S (377.1257)


   

2-[(2-methyl-4-benzofuro[3,2-d]pyrimidinyl)thio]-N-(2-phenylethyl)acetamide

2-[(2-methyl-4-benzofuro[3,2-d]pyrimidinyl)thio]-N-(2-phenylethyl)acetamide

C21H19N3O2S (377.1198)


   

3,4-Dimethyl-6-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,6-dihydropyrimidine-5-carboxylic acid propyl ester

3,4-Dimethyl-6-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,6-dihydropyrimidine-5-carboxylic acid propyl ester

C17H19N3O7 (377.1223)


   

N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine

N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine

C17H15N9S (377.1171)


   

N-ethyl-8-methyl-4-oxo-N-(phenylmethyl)-2-thieno[3,2-c][1]benzopyrancarboxamide

N-ethyl-8-methyl-4-oxo-N-(phenylmethyl)-2-thieno[3,2-c][1]benzopyrancarboxamide

C22H19NO3S (377.1086)


   

3-(4-methylphenyl)-5-oxo-N-propyl-8-thiazolo[2,3-b]quinazolinecarboxamide

3-(4-methylphenyl)-5-oxo-N-propyl-8-thiazolo[2,3-b]quinazolinecarboxamide

C21H19N3O2S (377.1198)


   
   

(2S)-2-[[(2-chlorophenyl)-oxomethyl]amino]-3-methylbutanoic acid (3-cyano-4-imino-2-oxopentyl) ester

(2S)-2-[[(2-chlorophenyl)-oxomethyl]amino]-3-methylbutanoic acid (3-cyano-4-imino-2-oxopentyl) ester

C18H20ClN3O4 (377.1142)


   

4,7-DI(Para-ethoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine

4,7-DI(Para-ethoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine

C21H19N3O2S (377.1198)


   

CBiPES

CBiPES

C21H19N3O2S (377.1198)


CBiPES is a potent mGlu2 positive allosteric modulator with an EC50 value of 92.8 nM. CBiPES attenuates stress-induced hyperthermia and Phencyclidine-induced hyperlocomotor activity. CBiPES can be used for research of neurological diseases[1][2].

   

CCT128930 (hydrochloride)

CCT128930 (hydrochloride)

C18H21Cl2N5 (377.1174)


CCT128930 hydrochloride is a potent and selective inhibitor of AKT (IC50=6 nM). CCT128930 hydrochloride has 28-fold selectivity over the closely related PKA kinase (IC50=168 nM) through the targeting of Met282 of AKT (Met173 of PKA-AKT chimera), as well as 20-fold selectivity over p70S6K (IC50=120 nM). CCT128930 hydrochloride induces cell cycle arrest, DNA damage, and autophagy. Antitumor activity[1][2].

   

mGluR2 antagonist 1

mGluR2 antagonist 1

C21H16FN3O3 (377.1176)


mGluR2 antagonist 1 is a highly potent, orally bioavailable and selective class of mGluR2 negative allosteric modulator (IC50 of 9 nM) with excellent brain permeability[1].

   

MLS-573151

MLS-573151

C21H19N3O2S (377.1198)


MLS-573151 (MLS000573151) is a selective GTPase Cdc42 inhibitor with an EC50 of 2 μM. MLS-573151 is inactive against other GTPases family members, such as Rab2, Rab7, H-Ras, Rac1, Rac 2 and RhoA wild-type. MLS-573151 acts by blocking the binding of GTP to Cdc42[1][2].

   

(2s,3r,4r,5r,6s)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-3-yl}oxy)-6-methyloxane-3,4,5-triol

(2s,3r,4r,5r,6s)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-3-yl}oxy)-6-methyloxane-3,4,5-triol

C17H19N3O7 (377.1223)


   

2-[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]ethanol

2-[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]ethanol

C22H19NO5 (377.1263)


   

(2r,3r,4s,5s,6r)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-3-yl}oxy)-6-methyloxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-3-yl}oxy)-6-methyloxane-3,4,5-triol

C17H19N3O7 (377.1223)


   

methyl 3-{4-acetyl-5-hydroxy-8-methylphenanthro[3,4-d][1,3]oxazol-2-yl}propanoate

methyl 3-{4-acetyl-5-hydroxy-8-methylphenanthro[3,4-d][1,3]oxazol-2-yl}propanoate

C22H19NO5 (377.1263)


   

2-({6-[(hydroxyimino)methyl]-[2,2'-bipyridin]-3-yl}oxy)-6-methyloxane-3,4,5-triol

2-({6-[(hydroxyimino)methyl]-[2,2'-bipyridin]-3-yl}oxy)-6-methyloxane-3,4,5-triol

C17H19N3O7 (377.1223)


   

2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

C18H19NO8 (377.1111)


   

7-(diethylamino)-3-(5-phenyl-1,3,4-thiadiazol-2-yl)chromen-2-one

7-(diethylamino)-3-(5-phenyl-1,3,4-thiadiazol-2-yl)chromen-2-one

C21H19N3O2S (377.1198)


   

(2r,3s,4s,5s,6s)-2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

(2r,3s,4s,5s,6s)-2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

C18H19NO8 (377.1111)


   

7-hydroxy-3-[4-methoxy-7-(3-methylbut-2-en-1-yl)-1,3-benzoxazol-6-yl]chromen-4-one

7-hydroxy-3-[4-methoxy-7-(3-methylbut-2-en-1-yl)-1,3-benzoxazol-6-yl]chromen-4-one

C22H19NO5 (377.1263)


   

11'-hydroxy-2-(2-hydroxyethyl)-7-methoxy-6'-methyl-3'-oxaspiro[isoindole-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),4',6',8',10'-pentaen-3-one

11'-hydroxy-2-(2-hydroxyethyl)-7-methoxy-6'-methyl-3'-oxaspiro[isoindole-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),4',6',8',10'-pentaen-3-one

C22H19NO5 (377.1263)


   

(3r,6r)-3-(1h-indol-3-ylmethyl)-6-isopropyl-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

(3r,6r)-3-(1h-indol-3-ylmethyl)-6-isopropyl-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

C18H23N3O2S2 (377.1232)


   

2-{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl}ethanol

2-{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl}ethanol

C22H19NO5 (377.1263)


   

3-(1h-indol-3-ylmethyl)-6-isopropyl-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

3-(1h-indol-3-ylmethyl)-6-isopropyl-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

C18H23N3O2S2 (377.1232)